psalexa
logo

Intrathecal Pumps Market

Global Intrathecal Pumps Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS10170
Available Format:

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Type of Drug

1.3.2. Market Segmentation by Application

1.3.3. Market Segmentation by End User

1.3.4. Market Segmentation by Geography

1.3.5. Analysis Period

1.3.6. Market Data Reporting Unit

1.3.6.1. Value

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents

2.2.1.1. By region

2.2.1.2. By industry participants

2.2.1.3. By company type

2.3. Market Size Estimation

2.4. Market Breakdown and Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Market Segmentation

4.1.1. Overview by Type of Drug

4.1.1.1. Baclofen

4.1.1.2. Hydromorphone

4.1.1.3. Morphine

4.1.1.4. Clonidine

4.1.1.5. Midazolam

4.1.1.6. Bupivacaine

4.1.1.7. Others

4.1.2. Overview by Application

4.1.2.1. Pain management

4.1.2.2. Spasticity management

4.1.3. Overview by End User

4.1.3.1. Hospitals

4.1.3.2. Clinics

4.1.3.3. Others

4.2. Value Chain Analysis

4.3. Market Dynamics

4.3.1. Trends

4.3.2. Drivers

4.3.2.1. Impact analysis of drivers on market forecast

4.3.3. Restraints

4.3.3.1. Impact analysis of restraints on market forecast

4.3.4. Opportunities

4.4. Porter’s Five Forces Analysis

Chapter 5. Market Size and Forecast by Type of Drug

5.1. Baclofen

5.2. Hydromorphone

5.3. Morphine

5.4. Clonidine

5.5. Midazolam

5.6. Bupivacaine

5.7. Others

Chapter 6. Market Size and Forecast by Application

6.1. Pain Management

6.2. Spasticity Management

Chapter 7. Market Size and Forecast by End User

7.1. Hospitals

7.2. Clinics

7.3. Others

Chapter 8. Market Size and Forecast by Geography

8.1. North America Intrathecal Pumps Market

8.1.1. By Type of Drug

8.1.2. By Application

8.1.2.1. Pain management, by number of procedures

8.1.2.2. Spasticity management, by number of procedures

8.1.3. By End User

8.1.4. By Country – The U.S. and Canada

8.2. Europe Intrathecal Pumps Market

8.2.1. By Type of Drug

8.2.2. By Application

8.2.2.1. Pain management, by number of procedures

8.2.2.2. Spasticity management, by number of procedures

8.2.3. By End User

8.2.4. By Country – The U.K., Germany, France, Italy, Spain and Rest of Europe

8.3. Asia-Pacific Intrathecal Pumps Market

8.3.1. By Type of Drug

8.3.2. By Application

8.3.2.1. Pain management, by number of procedures

8.3.2.2. Spasticity management, by number of procedures

8.3.3. By End User

8.3.4. By Country – Japan, China, India and Rest of Asia-Pacific

8.4. Latin America Intrathecal Pumps Market

8.4.1. By Type of Drug

8.4.2. By Application

8.4.2.1. Pain management, by number of procedures

8.4.2.2. Spasticity management, by number of procedures

8.4.3. By End User

8.4.4. By Country – Brazil and Rest of Latin America

8.5. Middle East & Africa Intrathecal Pumps Market

8.5.1. By Type of Drug

8.5.2. By Application

8.5.2.1. Pain management, by number of procedures

8.5.2.2. Spasticity management, by number of procedures

8.5.3. End User  

Chapter 9. Competitive Landscape

9.1. Competitive Analysis of Key Players

9.2. Global Strategic Developments

Chapter 10. Company Profiles

10.1. Codman & Shurtleff, Inc.

10.1.1. Business Overview

10.1.2. Product and Service Offerings

10.1.3. Strategic Growth Plan

10.2. Medtronic PLC

10.2.1. Business Overview

10.2.2. Product and Service Offerings

10.2.3. Strategic Growth Plan

10.3. Arrow International, Inc.

10.3.1. Business Overview

10.3.2. Product and Service Offerings

10.3.3. Strategic Growth Plan

10.4. Medallion Therapeutics, Inc.

10.4.1. Business Overview

10.4.2. Product and Service Offerings

10.4.3. Strategic Growth Plan

10.5. Flowonix, Inc.

10.5.1. Business Overview

10.5.2. Product and Service Offerings

10.5.3. Strategic Growth Plan

10.6. Tricumed Medizintechnik GmbH

10.6.1. Business Overview

10.6.2. Product and Service Offerings

10.6.3. Strategic Growth Plan

10.7. Johnson & Johnson

10.7.1. Business Overview

10.7.2. Product and Service Offerings

10.7.3. Strategic Growth Plan

10.8. Smiths Group PLC

10.8.1. Business Overview

10.8.2. Product and Service Offerings

10.8.3. Strategic Growth Plan

10.9. Summit Medical Products Inc.

10.9.1. Business Overview

10.9.2. Product and Service Offerings

10.9.3. Strategic Growth Plan

10.10. Becton, Dickinson and Company

10.10.1. Business Overview

10.10.2. Product and Service Offerings

10.10.3. Strategic Growth Plan

*Note: Strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.

Chapter 11. Appendix

11.1. Abbreviations

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry